Terms: = Endocrine gland cancer AND SMARCE1, ENSG00000073584, 6605, BAF57, Q969G3
6 results:
1. Targeting and monitoring ovarian cancer invasion with an RNAi and peptide delivery system.
Hao L; Boehnke N; Elledge SK; Harzallah NS; Zhao RT; Cai E; Feng YX; Neaher S; Fleming HE; Gupta PB; Hammond PT; Bhatia SN
Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307802121. PubMed ID: 38437557
[TBL] [Abstract] [Full Text] [Related]
2. A narrative review of targeted therapy in meningioma, pituitary adenoma, and craniopharyngioma of the skull base.
Martinez NL; Khanna O; Farrell CJ
Chin Clin Oncol; 2020 Dec; 9(6):75. PubMed ID: 32819111
[TBL] [Abstract] [Full Text] [Related]
3. Long noncoding RNA HOTTIP promotes the metastatic potential of ovarian cancer through the regulation of the miR-615-3p/smarce1 pathway.
Wu H; Wei HY; Chen QQ
Kaohsiung J Med Sci; 2020 Dec; 36(12):973-982. PubMed ID: 32783402
[TBL] [Abstract] [Full Text] [Related]
4. Expression of baf57 in ovarian cancer cells and drug sensitivity.
Yamaguchi T; Kurita T; Nishio K; Tsukada J; Hachisuga T; Morimoto Y; Iwai Y; Izumi H
Cancer Sci; 2015 Apr; 106(4):359-66. PubMed ID: 25611552
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of smarce1 is associated with CD8+ T-cell infiltration in early stage ovarian cancer.
Giannakakis A; Karapetsas A; Dangaj D; Lanitis E; Tanyi J; Coukos G; Sandaltzopoulos R
Int J Biochem Cell Biol; 2014 Aug; 53():389-98. PubMed ID: 24880093
[TBL] [Abstract] [Full Text] [Related]
6. Preoperative tumor marker CA125 levels in relation to epithelial ovarian cancer stage.
Fures R; Buković D; Hodek B; Klarić B; Herman R; Grubisić G
Coll Antropol; 1999 Jun; 23(1):189-94. PubMed ID: 10402722
[TBL] [Abstract] [Full Text] [Related]
